top of page



Precision Oncology   |   Prostate Cancer
 

About

About

White Structure
PRINT--10.jpg

Clinician. Researcher. Leader.

​

​

William K. Oh, MD is an expert in the management of prostate cancer and Clinical Professor of Medicine at the Icahn School of Medicine at Mount Sinai in NYC.    

 

He is a globally recognized translational research leader in Oncology and has been principal investigator of multiple therapeutic clinical trials with biomarker emphasis.  He has authored  >350 peer-reviewed publications.

 

He has had a distinguished academic career at Dana-Farber Cancer Institute, Harvard Medical School and Mount Sinai, building and overseeing the clinical research infrastructure at Mount Sinai as Deputy Director of the NCI-designated Tisch Cancer Institute.

 

He has had recent leadership roles as CMO of Sema4, a publicly traded genomics and health intelligence company, as well as Prostate Cancer Foundation, the leading philanthropy for prostate cancer research.  

Research

Dr. Oh has edited three books and published over 350 papers in peer-reviewed journals.

41q62yzYaeL._SY425_.jpeg
Speaking

Media

William Oh, MD, tells us how PSA is valuable as a biomarker in the treatment of prostate cancer

William Oh, MD, tells us how PSA is valuable as a biomarker in the treatment of prostate cancer

Play Video
image.png

New Guidelines: Start PSA Screening Earlier in Black Men.

image_edited.png

Prostate cancer shouldn't be a death sentence. But for a startling number of U.S. males, it is.

image.png

AI in Healthcare Analysis: PMWC 2023 Silicon Valley

image.png

38 top oncology AAPI physicians, per Castle Connolly

bottom of page